Back
Pfizer Inc. 10K Form
Sell
46
PFE
Pfizer Inc.
Last Price:
$26.60
Seasonality Move:
3.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-03-15 | 10K | PFE/Pfizer Inc. Annual |
| 2025-02-15 | 10K | PFE/Pfizer Inc. Annual |
| 2024-11-04 | 10Q | PFE/Pfizer Inc. Quarterly |
| 2024-08-05 | 10Q | PFE/Pfizer Inc. Quarterly |
| 2024-05-08 | 10Q | PFE/Pfizer Inc. Quarterly |
| 2024-02-22 | 10K | PFE/Pfizer Inc. Annual |
Receive PFE News And Ratings
See the #1 stock for the next 7 days that we like better than PFE
PFE Financial Statistics
Sales & Book Value
| Annual Sales: | $62.6B |
|---|---|
| Cash Flow: | $4.5B |
| Price / Cash Flow: | 16.7 |
| Annual Sales: | $15.21 |
| Price / Book: | 1.75 |
Profitability
| EPS (TTM): | 1.35510 |
|---|---|
| Net Income (TTM): | $7.8B |
| Gross Margin: | $41B |
| Return on Equity: | 8.69% |
| Return on Assets: | 3.73% |
Pfizer Inc. Earnings Forecast
Key Pfizer Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for PFE is 65.57%.
-
The Selling, General & Administrative Expenses for PFE have been equal to 22.04% of Gross Profit Margin.
-
The Research & Development expenses have been 16.37% of Revenue.
-
The Interest Expense is 34.30% of Operating Income.
-
The Net Earning history of PFE is 12.44% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 24 years.
Pfizer Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PFE |
| CUSIP: | 717081 |
| Website: | pfizer.com |
Debt
| Debt-to-Equity Ratio: | 0.78 |
|---|---|
| Current Ratio: | 1.16 |
| Quick Ratio: | 0.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.6 |
|---|---|
| Forward P/E Ratio: | 9.39 |
PFE Technical Analysis vs Fundamental Analysis
Sell
46
Pfizer Inc. (PFE)
is a Sell
Is Pfizer Inc. a Buy or a Sell?
-
Pfizer Inc. stock is rated a SellThe current Pfizer Inc. [PFE] share price is $26.58. The Score for PFE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.